Effect of vitamin E and beta carotene on the incidence of angina pectoris - A randomized, double-blind, controlled trial

被引:164
|
作者
Rapola, JM [1 ]
Virtamo, J [1 ]
Haukka, JK [1 ]
Heinonen, OP [1 ]
Albanes, D [1 ]
Taylor, PR [1 ]
Huttunen, JK [1 ]
机构
[1] NCI,BETHESDA,MD 20892
来源
关键词
D O I
10.1001/jama.275.9.693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To examine the effect of supplementation with vitamin E (alpha tocopherol), beta carotene, or both on the incidence of angina pectoris in men without known previous coronary heart disease. Design.-Randomized, double-blind, placebo-controlled trial. Setting and Participants.-Participants in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study (N=29 133) were male smokers aged 50 through 69 years who were living in southern and western Finland. Of these men, 22 269 were considered free of coronary heart disease at baseline and were followed up for the incidence of angina pectoris. Intervention.-Participants were randomized to receive 50 mg/d of alpha tocopherol, 20 mg/d of beta carotene, both, or placebo in a 2x2 design. Outcome Measures.-An incident case was defined as the first occurrence of typical angina pectoris identified in administering the annually repeated World Health Organization (Rose) Chest Pain Questionnaire. Results.-During a median follow-up time of 4.7 years (96 427 person-years), 1983 new cases of angina pectoris were detected. Comparing alpha tocopherol-supplemented subjects with non-alpha tocopherol-supplemented subjects showed a relative risk (RR) of angina pectoris incidence of 0.91 (95% confidence interval [CI], 0.83 to 0.99; P=.04). The RR for incidence of angina pectoris for the beta carotene-supplemented subjects compared with those not receiving beta carotene was 1.06 (95% CI, 0.97 to 1.16; P=.19). Compared with those receiving placebo, the RRs for incidence of angina pectoris were 0.97 (95% CI, 0.85 to 1.10) and 0.96 (95% CI, 0.85 to 1.09) in the alpha tocopherol and alpha tocopherol plus beta carotene groups respectively, and 1.13 (95% CI, 1.00 to 1.27) in the beta carotene group (P=.06). Baseline dietary intakes and serum levels of alpha tocopherol and beta carotene did not predict incidence of angina pectoris. Conclusions.-Supplementation with alpha tocopherol was associated with only a minor decrease in the incidence of angina pectoris. Beta carotene had no preventive effect and was associated with a slight increase in the incidence of angina.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 50 条
  • [21] BOPINDOLOL AND ATENOLOL IN PATIENTS WITH STABLE ANGINA-PECTORIS - DOUBLE-BLIND RANDOMIZED COMPARATIVE TRIAL
    HERTZEANU, H
    SHEMESH, J
    LOIDL, AF
    KELLERMANN, JJ
    CARDIOLOGY, 1989, 76 (04) : 312 - 318
  • [22] SUPERIORITY OF VERAPAMIL TO PROPRANOLOL IN STABLE ANGINA-PECTORIS - A DOUBLE-BLIND, RANDOMIZED CROSSOVER TRIAL
    FRISHMAN, WH
    KLEIN, NA
    STROM, JA
    WILLENS, H
    LEJEMTEL, TH
    JENTZER, J
    SIEGEL, L
    KLEIN, P
    KIRSCHEN, N
    SILVERMAN, R
    POLLACK, S
    DOYLE, R
    KIRSTEN, E
    SONNENBLICK, EH
    CIRCULATION, 1982, 65 (01) : I51 - I59
  • [23] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ORAL VERAPAMIL IN UNSTABLE ANGINA-PECTORIS
    MEHTA, J
    DAY, M
    WELDON, S
    CONTI, CR
    CLINICAL RESEARCH, 1981, 29 (02): : A223 - A223
  • [24] DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL
    ENGLISH, PMB
    TITCHEN, AC
    BRITISH JOURNAL OF GENERAL PRACTICE, 1992, 42 (354): : 37 - 38
  • [25] DOUBLE-BLIND, DOUBLE CROSS-OVER TRIAL OF PRENYLAMINE IN ANGINA PECTORIS
    WINSOR, T
    BLEIFER, K
    COLE, S
    GOLDMAN, IR
    KARPMAN, H
    OBLATH, R
    STONE, S
    AMERICAN HEART JOURNAL, 1971, 82 (01) : 43 - &
  • [26] EFFECT OF DILTIAZEM IN PATIENTS WITH VARIANT ANGINA - A RANDOMIZED DOUBLE-BLIND TRIAL
    PEPINE, CJ
    FELDMAN, RL
    WHITTLE, J
    CURRY, RC
    AMERICAN HEART JOURNAL, 1981, 101 (06) : 719 - 725
  • [27] VITAMIN D SUPPLEMENTATION IN PREGNANCY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
    Khadgawat, R.
    Kachhawa, G.
    Kulshreshtha, V.
    Gupta, T.
    Sreenivas, V.
    Gupta, N.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S50 - S50
  • [29] DOUBLE-BLIND TRIAL OF PERHEXILINE MALEATE IN PROPHYLAXIS OF ANGINA-PECTORIS
    BROWN, MJ
    HOROWITZ, JD
    MASHFORD, ML
    MEDICAL JOURNAL OF AUSTRALIA, 1976, 1 (09) : 260 - 263
  • [30] PERHEXILINE MALEATE IN TREATMENT OF ANGINA-PECTORIS - DOUBLE-BLIND TRIAL
    GITLIN, N
    NELLEN, M
    POSTGRADUATE MEDICAL JOURNAL, 1973, 49 : 100 - 104